DTL Is a Prognostic Biomarker and Promotes Bladder Cancer Progression through Regulating the AKT/mTOR axis

Title
DTL Is a Prognostic Biomarker and Promotes Bladder Cancer Progression through Regulating the AKT/mTOR axis
Authors
Keywords
-
Journal
Oxidative Medicine and Cellular Longevity
Volume 2022, Issue -, Pages 1-22
Publisher
Hindawi Limited
Online
2022-01-22
DOI
10.1155/2022/3369858

Ask authors/readers for more resources

Find the ideal target journal for your manuscript

Explore over 38,000 international journals covering a vast array of academic fields.

Search

Become a Peeref-certified reviewer

The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.

Get Started